Luc Grinand

Research Scientist

Dr. Luc Grinand is a neuroscience researcher with over a decade of experience in regenerative medicine, cell therapy, and iPS-derived lung models. He holds a PhD from Kyoto University and currently leads viral infection and drug testing research at HiLung Inc., using iPS cell-based respiratory systems. His expertise spans Parkinson’s disease therapy development, angiogenesis disorders, and antiviral screening under BSL-3 conditions.